Regeneron and other companies are working to develop ways to inject antibodies from recovered covid-19 patients into patients who are infected. Part of the research involves cloning antibodies from patients recovered in laboratories and using those clones as treatment. | #Podcast 🎧: Hear the latest on the coronavirus in the podcast “Coronavirus: Reality vs. fiction with doctor Elmer Huerta
Monoclonal antibodies, the hope of scientists
2020-05-07T22:21:21.247Z
Regeneron and other companies are working to develop ways to inject antibodies from recovered covid-19 patients into patients who are infected. Part of the research involves cloning ...